Complex I: Structure and Function as A Drug Target (P17215)

Target Name: Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I)

NCBI ID: P17215

Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I)

Other Name(s): None

Complex I: Structure and Function as A Drug Target

Mitochondrial membrane respiratory chain (MMC) is a complex protein that is responsible for producing the majority of the energy ATP in the cell through a process called cellular respiration. One of the key components of this complex is NADH dehydrogenase (Complex I), which plays a crucial role in the production of NADH, a crucial co-factor for the electron transport chain. In this article, we will discuss the structure and function of Complex I and its potential as a drug target.

Structure

Complex I is a protein that contains four subunits: E1, E2, E3, and E4. The subunits are held together by a series of hydrogen bonds and have a characteristic Rossmann-fold structure. E1 and E2 are the catalytic subunits, while E3 and E4 play structural roles.

Function

Complex I is the first enzyme in the MMC and is responsible for the production of NADH. NADH is a small molecule that plays a critical role in the electron transport chain, where it is used to produce ATP by reducing the level of oxygen in the electron transport chain.

The MMC is a multi-subunit protein that consists of four subunits: E1, E2, E3, and E4. The subunits are held together by a series of hydrogen bonds and have a characteristic Rossmann-fold structure. E1 and E2 are the catalytic subunits, while E3 and E4 play structural roles.

The MMC is responsible for the production of NADH through a series of intermediate steps. The first step in the pathway is the citric acid cycle, where E1, E2, and E3 are involved in the production of E2-cytidine (E2c) and E3-cytidine (E3c). The second step is the electron transport chain, where E4 is involved in the production of NADH.

The production of NADH by the MMC is a critical step in the production of ATP by cellular respiration. NADH is a small molecule that plays a critical role in the electron transport chain, where it is used to produce ATP by reducing the level of oxygen in the electron transport chain.

E1 and E2 are the catalytic subunits of Complex I and are responsible for the production of E2-cytidine and E3-cytidine. E2-cytidine is a key intermediate step in the production of NADH, while E3-cytidine is not directly involved in the production of NADH.

E3 and E4 play structural roles in the MMC. They help to maintain the stability of the complex and also play a role in the production of NADH.

Drug Target

Complex I is a potential drug target for the treatment of a variety of diseases. The MMC is a critical component of cellular respiration and the production of NADH is a critical step in this process. Therefore, inhibiting the activity of Complex I could be a useful way to treat diseases that are caused by disruptions in cellular respiration.

One of the potential benefits of targeting Complex I is that it is a protein that is expressed in high levels in many different tissues and organs. This makes it a potential target for small molecule inhibitors, which can be easily administered to patients.

Another potential benefit of targeting Complex I is that it is a protein that is involved in the production of NADH, which is a crucial co-factor for the electron transport chain. Therefore, inhibiting the activity of Complex I could be a useful way to treat diseases that are caused by disruptions in the electron transport chain.

Conclusion

In conclusion, Complex I is a protein that is involved in the production of NADH through the MMC. The MMC is a critical component of cellular respiration and the production of NADH is a critical step in this process. Therefore, targeting Complex I with small molecule inhibitors could be a useful way to treat diseases

Protein Name: Mitochondrial Membrane Respiratory Chain NADH Dehydrogenase (Complex I)

The "Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets